There are cannabis trade shows, there are cultural festivals, and then there is Mary Jane Berlin.
From June 11 to 14, 2026, Mary Jane Berlin returns to Messe Berlin for its 10th anniversary edition, bringing together the global cannabis industry, European consumers, medical cannabis stakeholders, entrepreneurs, investors, educators, artists, activists, media, and the kind of international community that only cannabis can pull into one room.
Actually, make that several rooms, stages, halls, outdoor spaces, networking areas, and festival zones.
Mary Jane Berlin has grown into the largest cannabis event in the world, and that is not marketing fluff. The official 2026 event is expected to welcome more than 75,000 attendees. Recent coverage points to more than 500 international exhibitors expected for the 10th anniversary edition. The 2025 edition already drew more than 65,000 visitors, including 5,000 industry professionals, more than 500 exhibitors, roughly 90 speakers, and hundreds of accredited journalists.
That is not a niche gathering anymore. That is a global marketplace.
For Beard Bros Pharms and Media, this is exactly why we are showing up. We will be attending Mary Jane Berlin as media partners, covering the event, connecting with operators, highlighting the people building the international cannabis industry, and bringing our audience inside one of the most important cannabis gatherings on the planet.
Because if you want to understand where cannabis is going next, you need to pay attention to Germany.
What Is Mary Jane Berlin?
Mary Jane Berlin is part cannabis expo, part business conference, part consumer festival, and part cultural checkpoint for the global cannabis movement.
The 2026 edition takes place at Messe Berlin, one of Europe’s major exhibition venues, with a dedicated B2B trade visitor day on June 11, followed by public expo and festival programming from June 12 through June 14.
That structure matters.
The first day gives industry professionals a focused environment for meetings, deal flow, education, product discovery, policy conversations, and international networking. Then the event opens up to the broader community, bringing consumers, patients, advocates, artists, wellness seekers, hemp entrepreneurs, and cannabis curious attendees into the experience.
That hybrid format is one of the reasons Mary Jane Berlin has become so powerful. Most events lean heavily in one direction. They are either buttoned-up business conferences where culture is treated like a side dish, or they are consumer festivals where serious industry conversations get lost in the smoke.
Mary Jane Berlin does both.
It gives operators a place to make moves, and it gives consumers a place to see, touch, learn, ask questions, celebrate, and participate in the future of the plant.
That is rare. That is valuable. That is why the world is watching.
Mary Jane Berlin 2026 by the Numbers
The numbers tell the story better than any hype ever could.
Mary Jane Berlin 2026 is expected to bring more than 75,000 attendees to Messe Berlin across four days. More than 500 exhibitors are expected to participate, representing cannabis brands, medical cannabis companies, hemp businesses, cultivation technology, accessories, CBD and wellness products, seed companies, vaporizer brands, international media, ancillary service providers, and emerging operators from across the global cannabis supply chain.
The 2025 event showed just how far Mary Jane Berlin has already come. More than 65,000 visitors attended. About 5,000 of them were industry professionals. More than 500 exhibitors filled the show floor. Around 90 speakers participated in the conference. Roughly 200 accredited journalists covered the event.
Those numbers put Mary Jane Berlin in a class of its own.
The event began in 2016 with about 9,000 visitors. A decade later, it has become a central meeting point for cannabis culture, cannabis commerce, medical cannabis, hemp innovation, and European legalization conversations.
That kind of growth does not happen by accident. It happens when timing, culture, regulation, business demand, consumer curiosity, and international attention all collide in the same city.
Welcome to Berlin.
Why Germany Has Become a Global Cannabis Hub
Germany is no longer just a country with cannabis potential. Germany is now one of the most important cannabis markets in the world.
On April 1, 2024, Germany’s Cannabis Act took effect, changing the legal and cultural landscape around the plant. The reform removed cannabis from the same level of legal stigma it had carried for decades, opened the door for adult possession and home cultivation under strict limits, and created a framework for nonprofit cultivation associations.
No, Germany did not create a California-style adult-use dispensary market. There are no flashy recreational retail chains on every corner. There is no national commercial adult-use sales system yet.
And that is exactly why Germany is so interesting.
Germany is building something different. It is cautious, complicated, medical-forward, heavily regulated, and deeply European in its approach. It is also massive.
Germany is the largest economy in Europe. It has one of the most important medical cannabis markets on the continent. Its pharmaceutical infrastructure is sophisticated. Its distribution systems are serious. Its patient access conversation is evolving. Its consumer culture is opening up. Its political decisions have ripple effects far beyond its own borders.
When Germany moves, Europe pays attention.
That is why global cannabis companies, investors, media platforms, equipment suppliers, wellness brands, medical operators, policymakers, educators, and advocacy groups are all watching the German market closely.
Mary Jane Berlin sits right at the center of that shift.
The Business Opportunity Behind the Festival Energy
Do not let the music, crowds, and festival atmosphere fool you. Mary Jane Berlin is serious business.
For brands trying to understand the European market, the event offers a real-time look at consumer behavior, product trends, packaging expectations, medical cannabis positioning, hemp innovation, vaporizer demand, retail-adjacent strategy, and the growing overlap between cannabis, wellness, lifestyle, and culture.
For North American companies, Mary Jane Berlin is especially important because Europe does not operate like the United States or Canada.
The rules are different. The consumer expectations are different. The medical infrastructure is different. The advertising environment is different. The compliance culture is different. The pace of reform is different.
That means brands cannot just copy and paste a U.S. cannabis playbook into Germany and expect it to work. The market will humble that approach fast.
Mary Jane Berlin gives companies a chance to listen before they launch, meet before they spend, and learn before they embarrass themselves. That alone is worth the flight.
The event floor is where companies can see which categories are gaining traction, which operators are earning trust, which international brands are resonating, and which trends are just noise wearing a lanyard.
And there will be plenty of lanyards.
Why Consumers Matter at Mary Jane Berlin
One of the smartest things about Mary Jane Berlin is that it does not treat consumers as an afterthought.
Cannabis consumers are not just end users. They are culture carriers. They are patients. They are educators. They are early adopters. They are critics. They are voters. They are the people who decide whether a product, brand, movement, or policy actually lands in real life.
By opening the event to the public after the B2B day, Mary Jane Berlin creates a feedback loop that many industry-only events miss.
Brands get to engage directly with the people they hope to serve. Consumers get to explore products, attend educational programming, discover new companies, and participate in a cannabis environment that feels safer, more professional, and more normalized than the underground spaces many people have relied on for years.
That matters in Germany because legalization is still young.
Consumers are learning what legal cannabis culture looks like. Businesses are learning how to communicate responsibly. Policymakers are watching implementation. Medical operators are navigating growth. Advocates are pushing for fair access, practical rules, and continued reform.
Mary Jane Berlin brings all of those audiences together under one roof.
That is how markets mature.
Cannabis Culture Still Runs the Show
Cannabis is a business, but it is not only a business. The industry forgets that at its own risk.
Mary Jane Berlin understands the assignment.
The event blends commerce with music, education, wellness, product discovery, community, and cultural programming. That mix is not decoration. It is the point.
Cannabis culture built the foundation long before legal markets showed up with pitch decks and QR codes. The brands that will last in Germany, Europe, and beyond are the ones that understand how to respect that foundation while still building professional, compliant, scalable businesses.
That balance is hard. It is also where the best cannabis operators live.
At Mary Jane Berlin, that tension is visible in the best way. You can have a serious conversation about medical access, then walk into a consumer activation. You can meet international executives, then hear from advocates. You can see product innovation, then watch culture do what culture does.
It is messy, alive, human, and useful.
In other words, it feels like cannabis.
Beard Bros Pharms and Media Will Be on the Ground
Beard Bros Pharms and Media will be attending Mary Jane Berlin as media partners, and we are coming with a clear mission.
We want to cover the people, companies, ideas, policies, products, and cultural moments shaping the next chapter of global cannabis.
Our roots are in cannabis culture, advocacy, media, and business. We have spent years telling the stories that too often get sanitized, ignored, or flattened by mainstream coverage. Mary Jane Berlin gives us a chance to bring that same lens to one of the most important international cannabis events in the world.
We will be looking at the event from every angle: the business opportunities, the medical cannabis conversations, the consumer trends, the international partnerships, the policy signals, the cultural energy, and the lessons U.S. operators should be paying attention to.
Because the global cannabis industry is not waiting for the United States to get its federal act together.
Germany is moving. Europe is watching. International operators are positioning. Consumers are showing up. The next phase of cannabis is being shaped in real time.
We plan to be there to document it.
What U.S. Cannabis Operators Should Watch
For U.S. cannabis brands, Mary Jane Berlin offers more than international curiosity. It offers perspective.
The American cannabis industry has spent years navigating fragmented state markets, federal prohibition, tax burdens, banking barriers, platform censorship, overregulation, underregulation, price compression, and the occasional political circus act. You know, the usual relaxing startup environment.
Germany has different challenges, but the lessons are valuable.
U.S. operators should watch how German and European companies communicate around medical cannabis, wellness, compliance, sustainability, product education, and consumer trust. They should watch how brands position themselves without relying on the same advertising channels that dominate mainstream consumer packaged goods. They should watch how culture and regulation interact in a market that is still forming its legal identity.
They should also pay close attention to the role of media.
In emerging markets, education drives adoption. Trust drives conversion. Storytelling drives legitimacy. The companies that can explain what they do, why it matters, and who they serve will have an advantage.
That is true in Germany. It is true in the United States. It is true everywhere cannabis is still fighting outdated stigma while building modern infrastructure.
What Makes the 2026 Edition Special
The 2026 edition marks 10 years of Mary Jane Berlin.
That milestone arrives at a critical moment. Germany has moved beyond theory and into implementation. Cannabis reform is no longer just a debate. It is now part of public life, patient access, business planning, cultural programming, and international market strategy.
The event is also getting bigger. With more than 75,000 attendees expected, Mary Jane Berlin 2026 is positioned to set a new benchmark for what a global cannabis gathering can look like.
This is not just a celebration of one event’s growth. It is a signal that cannabis has entered a new international phase.
The plant is no longer trapped inside isolated national conversations. Cannabis is moving across borders through medical research, patient demand, consumer culture, hemp innovation, technology, investment, media, advocacy, and policy reform.
Mary Jane Berlin is where many of those threads meet.
Cannabis is at a strange and important crossroads.
In the United States, federal reform remains frustratingly slow. In Europe, medical markets are expanding while adult-use frameworks develop carefully and unevenly. In Germany, legalization has created momentum, but also complexity. Around the world, consumers are becoming more educated, more selective, and more interested in plant-based wellness, harm reduction, and alternatives to outdated drug policy.
That makes events like Mary Jane Berlin more important than ever.
They create visibility. They create connection. They create pressure. They create opportunity. They give the industry a place to compare notes, challenge assumptions, and see what is actually happening outside of our own bubbles.
For cannabis businesses, that is intelligence.
For consumers, that is access.
For advocates, that is momentum.
For media, that is a story worth telling.
/
Berlin Is Where the Global Cannabis Conversation Is Happening
Mary Jane Berlin 2026 is not just another date on the cannabis calendar. It is one of the clearest signs that the global cannabis industry is growing up, spreading out, and becoming more connected.
The event brings together the business of cannabis and the culture of cannabis without pretending those two worlds are separate. It reflects Germany’s rise as a hub for medical cannabis, consumer curiosity, European policy conversations, and international market strategy. It gives brands, operators, patients, consumers, advocates, and media a place to meet face to face.
That still matters. Maybe now more than ever.
Beard Bros Pharms and Media will be there as media partners, and we will be covering Mary Jane Berlin with the same approach we bring to everything in cannabis: honest, curious, culture-first, business-aware, and allergic to corporate nonsense.
Berlin is calling.
The world’s cannabis community is answering.
And we will see you at Mary Jane Berlin.
Heading to Mary Jane Berlin 2026? Connect with Beard Bros Pharms and Media before the event to talk media coverage, partnerships, international cannabis trends, advertising opportunities, and how your brand can show up with more strategy and less fluff.
Frequently Asked Questions
Mary Jane Berlin 2026 takes place June 11 to 14, 2026 at Messe Berlin in Berlin, Germany. June 11 is the B2B trade visitor day, while the expo and festival run from June 12 to 14.
Mary Jane Berlin is held at Messe Berlin, Hammarskjöldplatz, North Entrance, 14055 Berlin, Germany.
Mary Jane Berlin 2026 is expected to welcome more than 75,000 attendees. The 2025 edition drew more than 65,000 visitors, including about 5,000 industry professionals.
Mary Jane Berlin 2026 is expected to feature more than 500 international exhibitors across cannabis, hemp, medical cannabis, cultivation, accessories, wellness, technology, and ancillary business categories.
Mary Jane Berlin is important because it brings together global cannabis businesses, consumers, advocates, medical cannabis leaders, media, and culture in one of the most influential cannabis markets in Europe.
Germany is Europe’s largest economy and one of the continent’s most important medical cannabis markets. Since its 2024 cannabis reform, Germany has become a key country for international cannabis business, patient access, policy development, and consumer trends.
